Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Infect Dis Clin North Am. 2019 Mar;33(1):135–151. doi: 10.1016/j.idc.2018.10.006

Table 3.

Drugs used for strongyloidiasis

Drug Formulation Most relevant adverse events Contraindications and warnings
Ivermectin 3 and 6mg tablets Encephalopathy in those with high levels (>20000/ml) of Loa loa microfilariae (mf) Confirmed high levels of Loa loa mf
< 15kg body weight
Pregnancy
Lactating women on 1st wk of puerperium
Albendazole 200 and 400mg tablets Choking in infants 1st trimester pregnancy
Effective contraception is recommended during therapy and for 1 month after the last dose
Thiabendazole Tablets,
500 mg
Suspension,
500 mg/5 mL		 Gastrointestinal: anorexia, nausea, vomiting, diarrhea, abdominal pain, jaundice, parenchymal liver damage.
Central Nervous System: dizziness, weariness, drowsiness, headache, hyperirritability, seizures, tinnitus		 Activities requiring mental alertness should be avoided.